The Use of Biochemical Markers of Bone Turnover in Osteoporosis

By P. Delmas, Richard Eastell, P. Garnero, M. Seibel, J. Stepan, for the Committee of Scientific Advisors of the Intern Foundation. Osteoporosis International, 2000

731 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Orthopedics and Sports Medicine

View Paper: https://www.semanticscholar.org/paper/24cee1fb798c0dda41d36e1568f2e3f5191698a6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Oncology

In Orthopedics and Sports Medicine

Citations in the corpus

Alcohol intake as a risk factor for fracture (2005, background): “Examples include smoking, a prior fracture, prolonged use of corticosteroids, a family history of fracture, and biochemical indexes of skeletal turnover, all of which have been shown to provide independent contributions to fracture risk [48, 49, 50, 51].”
Smoking and fracture risk: a meta-analysis (2005, background): “These include a history of fracture, corticosteroid exposure, a family history of fracture, secondary osteoporosis, and possibly the biochemical indices of bone turnover [15, 51, 52, 53, 54].”
European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, background): “Bone markers are increased after the menopause, and in several studies the rate of bone loss varies according to the marker value [72].”
European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “Bonemarkers are increased after themenopause, and in several studies, the rate of bone loss varies according to the marker value [72].”
Epidemiology, etiology, and diagnosis of osteoporosis. (2006, background): “Multiple assays are now available that canmeasure these products relatively quickly and inexpensively.62 Tartrate-resistant acid phosphatase, which is a lysosomal enzyme present in cells, until recently was limited as a bone-resorption marker because early assays lacked specificity for the osteoclas”
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards (2011, background): “Increased BTMs in early menopause have an 80% sensitivity for detecting fast bone losers (bone loss >3%/ year) at the forearm in the next 2–12 years, but they have not been shown to be sufficiently predictive of bone loss at the hip or spine in individual patients [135].”
A meta-analysis of previous fracture and subsequent fracture risk. (2004, background): “These include smoking, corticosteroid exposure, a family history of fracture, secondary osteoporosis [39], and possibly the biochemical indices of bone turnover [63].”